SLE patients had a significantly reduced percentage of B cells and also reduced proportions of CD19+IgD+CD27+ and CD19+IgD-CD27+ cells, with a clear shift to CD19+IgD-CD27- (DN) B cells. The gene discussed is CD27; the disease is systemic lupus erythematosus.